Specifically, emerging evidence links altered BDNF trafficking to autism spectrum disorder, schizophrenia, major depressive disorder (MDD), bipolar disorder, Alzheimer’s disease (AD), and Huntington’s disease (HD). The gene discussed is BDNF; the disease is major depressive disorder.